Rénibus Therapeutics
Steve D. currently serves as Vice President of Program Management at Renibus Therapeutics Inc since October 2023. Prior to this role, Steve D. was the Principal CEO of Clinical Operational Excellence & Project Management Consulting, LLC from November 2022 to October 2023, focusing on clinical operations and project management consulting. Steve D. held the position of Senior Vice President of Clinical Operations at Arch Oncology from July 2021 to November 2022 and served as Vice President of Clinical Operations at Xencor from March 2014 to June 2021. Additionally, between May 2008 and January 2013, Steve D. was the Executive Director of Oncology Program Management at Geron, where responsibilities included leading teams and managing therapeutic area programs. Steve D. is an alumnus of the University of Michigan.
This person is not in any teams
This person is not in any offices
Rénibus Therapeutics
Rénibus Therapeutics is a biotech company dedicated to transforming the cardio-renal disease treatment paradigm by focusing on the prevention, treatment, and diagnostic testing of kidney disease.